Product Information
ZAFIRLUKAST 20 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.6762 per EA under NDC 64380018801. Its NADAC has been published 200 times since Aug 31, 2022.
Strength
20 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380018801
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ZAFIRLUKASTApproval Type
New Drug (NDA)
FDA Application
NDA020547On Market Since
8/1/2022
Pharmacological Classes
Price Statistics
The NADAC for ZAFIRLUKAST 20 MG TABLET has been published 200 times since Aug 31, 2022, and over the history we have for it it has declined 19.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6762 per EA |
|---|---|
| All-time high | $0.9991 (Dec 13, 2023) |
| All-time low | $0.4512 (Nov 20, 2024) |
| 52-week high | $0.7124 |
| 52-week low | $0.6446 |
| Median price | $0.7124 |
| Average price | $0.7370 |
| Largest weekly change | -33.6% (Nov 20, 2024) |
| Weeks tracked | 200 |
| Tracking since | Aug 31, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the zafirlukast market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ZAFIRLUKAST 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZAFIRLUKAST 20 MG TABLET, manufactured by Strides Pharma Inc., is $0.6762 per EA (NDC 64380018801), effective Jun 24, 2026.
How has the price of ZAFIRLUKAST 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZAFIRLUKAST 20 MG TABLET has declined 19.5%. It has been tracked across 200 weekly CMS publications since Aug 31, 2022.
What are the highest and lowest recorded NADAC prices for ZAFIRLUKAST 20 MG TABLET?
Since Aug 31, 2022, the NADAC for ZAFIRLUKAST 20 MG TABLET has ranged from a low of $0.4512 (Nov 20, 2024) to a high of $0.9991 (Dec 13, 2023), with a median of $0.7124 per EA.
Are there cheaper alternatives to ZAFIRLUKAST 20 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ZAFIRLUKAST 20 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ZAFIRLUKAST 20 MG TABLET?
ZAFIRLUKAST 20 MG TABLET (NDC 64380018801) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification